Clicky

Sprint Bioscience AB(SPRINT)

Description: Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB (publ) was founded in 2009 and is based in Huddinge, Sweden.


Keywords: Pharmaceutical Cancer Pharmaceutical Products Diabetes Treatment Of Cancer Tumor Treatment Of Various Types Of Cancer

Home Page: www.sprintbioscience.com

Novum
Huddinge, 141 57
Sweden
Phone: 46 84 11 44 55


Officers

Name Title
Mr. Erik Kinnmann Assoc. Prof., M.B.A., M.D., Ph.D. Chief Exec. Officer
Prof. Pär Nordlund Founder
Dr. Martin Andersson Co-Founder & Chief Scientific Officer
Ms. Jessica Martinsson MSc Founder & COO
Dr. Kenth Hallberg Founder & Director of Structural Chemistry
Mr. Mathias Skalmstad Chief Financial Officer
Ms. Anne-Marie Wenthzel Chief Bus. Officer

Exchange: ST

Country: SE : Sweden

Currency: Swedish krone (kr)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.6083
Price-to-Sales TTM: 27.0919
IPO Date:
Fiscal Year End: December
Full Time Employees: 34
Back to stocks